Association between -786TC polymorphism in the endothelial nitric oxide synthase gene and hypertension in the Tunisian population

Experimental and Molecular Pathology

Volumn 90, Issue 2, 2011, Pages 210-214

  Jemaa, Riadh ^a   Kallel, Amani ^a   Sediri, Yousra ^a   Omar, Souheil ^a   Feki, Moncef ^a   Elasmi, Monia ^a   Haj Taieb, Samah ^a   Sanhaji, Haïfa ^a   Kaabachi, Naziha ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Hypertension; Nitric oxide; NOS3 gene polymorphism

Indexed keywords

CYTOSINE; THYMINE;

ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; ENDOTHELIAL NITRIC OXIDE SYNTHASE GENE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENOTYPE; HUMAN; HUMAN CELL; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; POPULATION GENETICS; POPULATION RESEARCH; RISK ASSESSMENT; TUNISIA;

CONFIDENCE INTERVALS; DEMOGRAPHY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE TYPE III; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX CHARACTERISTICS; TUNISIA;

EID: 79151482884     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2010.12.006     Document Type: Article

References (45)

1. Alvarez R., Gonzalez P., Batalla A., Reguero J.R., Iglesias-Cubero G., Hevia S., Cortina A., Merino E., Gonzalez I., Alvarez V., Coto E. Association between the NOS3 (-786T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. Nitric Oxide 2001, 5:343-348.
2. Benjafield A.V., Morris B.J. Association analyses of endothelial nitric oxide synthase gene polymorphisms in essential hypertension. Am. J. Hypertens. 2000, 13:994-998.
3. Casas J.P., Bautista L.E., Humphries S.E., Hingorani A. Endothelial nitric oxide synthase genotype and ischemic heart disease. Meta-analysis of 26 studies involving 23,028 subjects. Circulation 2004, 109:1359-1365.
4. Crawford D.C., Nickerson D.A. Definition and clinical importance of haplotypes. Annu. Rev. Med. 2005, 56:303-320.
5. Forte P., Copland M., Smith L.M., Milne E., Sutherland J., Benjamin N. Basal nitric oxide synthesis in essential hypertension. Lancet 1997, 349:837-842.
6. Ghilardi G., Biondi M.L., DeMonti M., Benini M., Turri O., Massaro F., Guagnellini E., Scorza R. Independent risk factor for moderate to severe internal carotid artery stenosis: T786C mutation of the endothelial nitric oxide synthase gene. Clin. Chem. 2002, 48:989-993.
7. Hibi K., Ishigami T., Tamura K., Mizushima S., Nyui N., Fujita T., Ochiai H., Kosuge M., Watanabe Y., Yoshii Y., Kihara M., Kimura K., Ishii M., Umemura S. Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction. Hypertension 1998, 32:521-526.
8. Hingorani A.D. Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis 2001, 154:521-527.
9. Hingorani A.D., Liang C.F., Fatibene J., Lyon A., Monteith S., Parsons A., Haydock S., Hopper R.V., Stephens N.G., O'Shaughnessy K.M., Brown M.J. A common variant of the endothelial nitric oxide synthase (Glu298Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999, 100:1515-1520.
10. Hung P.L., Huang Z., Mashimo H., Bloch K.D., Moskowitz M.A., Bevan J.A., Fishman M.C. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995, 377:239-242.
11. Hyndman M.E., Parsons H.G., Verma S., Bridge P.J., Edworthy S., Jones C., Lonn E., Charbonneau F., Anderson T.J. The T-786→C mutation in endothelial nitric oxide synthase is associated with hypertension. Hypertension 2002, 39:919-922.
12. Ichihara S., Yamada Y., Fujimura T., Nakashima N., Yokoto M. Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population. Am. J. Cardiol. 1998, 81:83-86.
13. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., Chaudhuri G. Endothelium derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl Acad. Sci. USA 1987, 84:9265-9269.
14. Jachymova M., Horky K., Bultas J., Kozich V., Jindra A., Peleska J., Martasek P. Association of the Glu298Asp polymorphism in the endothelial nitric oxide synthase gene with essential hypertension resistant to conventional therapy. Biochem. Biophys. Res. Commun. 2001, 284:426-430.
15. Jemaa R., Kallel A., Ben Ali S., Omar S., Chabrak S., Elasmi M., Haj-Taieb S., Sanhaji H., Feki M., Mechmeche R., Kaabachi N. Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with myocardial infarction in Tunisian patients. Clin. Chem. Lab. Med. 2007, 45:1476-1480.
16. Jemaa R., Ben Ali S., Kallel A., Feki M., Elasmi M., Haj-Taieb S., Sanhaji H., Omar S., Kaabachi N. Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with hypertension in a Tunisian population. Clin. Biochem. 2009, 42:852-856.
17. Jia C., Liu T., Liu Z., Li M., Hu M. Joint effects of eNOS gene T-786C and ADH2 Arg47His polymorphisms on the risk of premature coronary artery disease. Thromb. Res. 2007, 120:679-684.
18. Johnson G.C.L., Esposito L., Barratt B.J., Smith A.N., Heward J., Di Genova G., Ueda H., Cordell H.J., Eaves I.A., Dudbridge F., Twells R.C.J., Payne F., Hughes W., Nutland S., Stevens H., Carr P., Tuomilehto-Wolf E., Tuomilehto J., Gough S.C.L., Clayton D.G., Todd J.A. Haplotype tagging for the identification of common disease genes. Nat. Genet. 2001, 29:233-237.
19. Kajiyama N., Saito Y., Miyamoto Y., Yoshimura M., Nakayama M., Harada M., Kuwahara K., Kishimoto I., Yasue H., Nakao K. Lack of association between T-786→C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene and essential hypertension. Hypertens. Res. 2000, 23:561-565.
20. Karvonen J., Kauma H., Kervinen K., Rantala M., Ikäheimo M., Päivänsalo M., Savolainen M.J., Kesäniemi Y.A. Endothelial nitric oxide synthase gene Glu298Asp polymorphism and blood pressure, left ventricular mass and carotid artery atherosclerosis in a population based cohort. J. Intern. Med. 2002, 251:102-110.
21. Linder L., Kiowski W., Buhler F.R., Luscher T.F. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990, 81:1762-1767.
22. Marcadet A., O'Connel P., Cohen D. Standardized Southern blot workshop techniques. Histocompatibility Testing 1987, 587-590. Springer, New York. B. Dupont (Ed.).
23. Marroni A.S., Metzger I.F., Souza-Costa D.C., Nagassaki S., Sandrim V.C., Correa R.X., Rios-Santos F., Tanus-Santos J.E. Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms. Nitric Oxide 2005, 12:177-182.
24. Miyamoto Y., Saito Y., Kajiyama N., Yoshimura M., Shimasaki Y., Nakayama M., Kamitani S., Harada M., Ishikawa M., Kuwahara K., Ogawa E., Hamanaka I., Takahashi N., Kaneshige T., Teraoka H., Akamizu T., Azuma N., Yoshimasa Y., Yoshimasa T., Itoh H., Masuda I., Yasue H., Nakao K. Endothelial nitric oxide synthase gene is positively associated with essential hypertension. Hypertension 1998, 32:3-8.
25. Miyamoto Y., Saito Y., Nakayama M., Shimasaki Y., Yoshimura T., Yoshimura M., Harada M., Kajiyama N., Kishimoto I., Kuwuhara K., Hino J., Ogawa E., Hamanaka I., Kamitani S., Takahashi N., Kawakami R., Kangawa K., Yasue H., Nakao K. Replication protein AI reduces transcription of the endothelial nitric oxide synthase gene containing a -786T→C mutation associated with coronary spastic angina. Hum. Mol. Genet. 2000, 9:2629-2637.
26. Nakayama M., Yasue H., Yoshimura M., Shimasaki Y., Kugiyama K., Ogawa H., Motoyama T., Saito Y., Ogawa Y., Miyamoto Y., Nakao K. T-786→C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999, 99:2864-2870.
27. Ogawa H., Motoyama T., Saito Y., Ogawa Y., Miyamoto Y., Nakao K. T-786→C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999, 99:2864-2870.
28. Panza J.A., Quyyumi A.A., Brush J.E., Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with hypertension. N. Engl. J. Med. 1990, 323:22-27.
29. Panza J.A., Garcia C.E., Kilcoyne C.M., Quyyumi A.A., Cannon R.O. Impaired endothelium-dependent vasodilation in patients with essential hypertension: evidence that nitric oxide abnormality is not localized to a single signal transduction pathway. Circulation 1995, 91:1732-1738.
30. Sandrim V.C., Coelho E.B., Nobre F., Arado G.M., Lanchote V.L., Tanus-Santos J.E. Susceptible and protective eNOS haplotypes in hypertensive black and white subjects. Atherosclerosis 2006, 186:428-432.
31. Sandrim V.C., de Syllos R.W.C., Lisboa H.R.K., Tres G.S., Tanus-Santos J.E. Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus. Atherosclerosis 2006, 189:241-246.
32. Sandrim V.C., Yugar-Toledo J.C., Desta Z., Flockhart D.A., Moreno H., Tanus-Santos J.E. Endothelial nitric oxide synthase haplotypes and resistance to antihypertensive drug therapy. J. Hypertens. 2006, 24:2393-2397.
33. Sandrim V.C., de Syllos R.W.C., Lisboa H.R.K., Tres G.S., Tanus-Santos J.E. Influence of eNOS haplotypes on the plasma nitric oxide products concentrations in hypertensive and type 2 diabetes mellitus patients. Nitric Oxide 2007, 16:348-355.
34. Shoji M., Tsutaya S., Saito R., Takamatu H., Yasujima M. Positive association of endothelial nitric oxide synthase gene polymorphism with hypertension in northern Japan. Life Sci. 2000, 66:2557-2562.
35. Takaoka M. NOS gene polymorphism. Nippon Rinsho 2004, 62:103-109.
36. Tanus-Santos J.E., Desai M., Flockhart D.A. Effects of ethnicity on the distribution of clinically relevant endothelial nitric oxide variants. Pharmacogenetics 2001, 11:719-725.
37. Tanus-Santos J.E., Desai M., Deak L.R., Pezzullo J.C., Abernethy D.R., Flockhart D.A., Freedman J.E. Effects of endothelial nitric oxide synthase gene polymorphisms on platelet function, nitric oxide release, and interactions with estradiol. Pharmacogenetics 2002, 12(5):407-413.
38. Tsujita Y., Baba S., Yamauchi R., Mannami T., Kinoshita M., Yamamoto R., Katsuya T., Higaki J., Ogihara T., Ogata J., Iwai N. Association analyses between genetic polymorphisms of endothelial nitric oxide synthase gene and hypertension in Japanese: the Suita study. J. Hypertens. 2001, 19:1941-1948.
39. Uwabo J., Soma M., Nakayama T., Kanmatsuse K. Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essential hypertension in Japanese. Am. J. Hypertens. 1998, 11:125-128.
40. Wang X.L., Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol. Genet. Metab. 2000, 70:241-251.
41. Wang X.L., Sim A.S., Badenhop R.F., McCredie R.M., Wilcken D.E. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene. Nat. Med. 1996, 2:41-45.
42. World Health Organization Physical status: the use and interpretation anthropometry: report of a WHO expert committee. WHO Technical Report Series, no. 854 1995, 321-324. WHO, Genova.
43. World Health Organization International society of hypertension guideline for the management of hypertension. J. Hypertens. 1999, 17:151-183.
44. Yoshimura M., Yasue H., Nakayama M., Shimasaki Y., Sumida H., Sugiyama S., Kugiyama K., Ogawa H., Ogawa Y., Saito Y., Miyamoto Y., Nakao K. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum. Genet. 1998, 103:65-69.
45. Yoshimura M., Yasue H., Nakayama M., Shimasaki Y., Ogawa H., Kugiyama K., Saito Y., Miyamoto Y., Ogawa Y., Kaneshige T., Hiramatsu H., Yoshioka T., Kamitani S., Teraoka H., Nakao K. Genetic risk factors for coronary artery spasm; significance of endothelial nitric oxide synthase gene T-786→C and missence Glu298Asp variants. J. Investig. Med. 2000, 48:367-374.